Long-TermIn VivoGene Expression via Delivery of PEI–DNA Condensates from Porous Polymer Scaffolds
- 1 May 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 16 (5) , 609-617
- https://doi.org/10.1089/hum.2005.16.609
Abstract
Nonviral delivery vectors are attractive for gene therapy approaches in tissue engineering, but suffer from low transfection efficiency and short-term gene expression. We hypothesized that the sustained delivery of poly(ethylenimine) (PEI)-condensed DNA from three-dimensional biodegradable scaffolds that encourage cell infiltration could greatly enhance gene expression. To test this hypothesis, a PEI-condensed plasmid encoding β-galactosidase was incorporated into porous poly(lactide-co-glycolide) (PLG) scaffolds, using a gas foaming process. Four conditions were examined: condensed DNA and uncondensed DNA encapsulated into PLG scaffolds, blank scaffolds, and bolus delivery of condensed DNA in combination with implantation of PLG scaffolds. Implantation of scaffolds incorporating condensed β-galactosidase plasmid into the subcutaneous tissue of rats resulted in a high level of gene expression for the entire 15-week duration of the experiment, as exemplified by extensive positive staining for β-galactosidase gene expression observed on the exterior surface and throughout the cross-sections of the explanted scaffolds. No positive staining could be observed for the control conditions either on the exterior surface or in the cross-section at 8- and 15-week time points. In addition, a high percentage (55–60%) of cells within scaffolds incorporating condensed DNA at 15 weeks demonstrated expression of the DNA, confirming the sustained uptake and expression of the encapsulated plasmid DNA. Quantitative analysis of β-galactosidase gene expression revealed that expression levels in scaffolds incorporating condensed DNA were one order of magnitude higher than those of other conditions at the 2- week time point and nearly two orders of magnitude higher than those of the control conditions at the 8- and 15-week time points. This study demonstrated that the sustained delivery of PEI–condensed plasmid DNA from PLG scaffolds led to an in vivo long-term and high level of gene expression, and this system may find application in areas such as bone tissue engineering.Keywords
This publication has 45 references indexed in Scilit:
- Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene DeliveryBioconjugate Chemistry, 2001
- Biomaterial developments for bone tissue engineeringBiomaterials, 2000
- Sustained delivery and expression of DNA encapsulated in polymeric nanoparticlesGene Therapy, 2000
- Tissue engineering via local gene deliveryJournal of Molecular Medicine, 2000
- Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regenerationNature Medicine, 1999
- Gene therapy for tissue repair and regenerationAdvanced Drug Delivery Reviews, 1998
- Expression of Biologically Active Human Insulin-like Growth Factor-I Following Intramuscular Injection of a Formulated Plasmid in RatsHuman Gene Therapy, 1997
- Nonviral Gene Delivery to the Rat Kidney with PolyethylenimineHuman Gene Therapy, 1997
- Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage librariesNature Medicine, 1996
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995